VKH
BIS icon

Virtu KCG Holdings’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Virtu KCG Holdings’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,433
Closed -$319K – 2897
2017
Q1 		$319K Buy
1,433
+600
+72% +$142K 0.01% 1876
2016
Q4 		$233K Buy
+833
New +$228K 0.01% 2394
2015
Q1 		– Sell
-585
Closed -$215K – 3159
2014
Q4 		$215K Buy
+585
New +$244K ﹤0.01% 2798

Other funds holding BIS

HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Virtu KCG Holdings's BIS Position: Q2 2017 in Review

Virtu KCG Holdings sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q2 2017, closing a stake of 1,433 shares — an estimated $319K sold.

Virtu KCG Holdings first reported a position in BIS in Q4 2014 and held it in 3 quarters. The position peaked at $319K in Q1 2017. 12 funds tracked by Wall St. Rank hold BIS as of Q2 2017.

  • Virtu KCG Holdings reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 1,433 ProShares UltraShort NASDAQ Biotechnology shares in Q2 2017, an estimated $319K.
  • Virtu KCG Holdings first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q4 2014 and held it in 3 quarters.
  • Virtu KCG Holdings's ProShares UltraShort NASDAQ Biotechnology position peaked at $319K in Q1 2017.
  • 12 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.